XTMAB-16 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-11 (month) in 3mo
ESTIMATED |
READOUT
An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Phase 2 · Pulmonary Sarcoidosis |
Xentria, Inc. | XTMAB-16 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|